Healthcare - Biotechnology - NASDAQ - US
$ 18.09
-0.768 %
$ 95.5 M
Market Cap
-9.62
P/E
Price Target
Average
21.61%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--28.93%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Monopar Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for MNPR of $22 , with forecasts ranging from a low of $22 to a high of $22 .
MNPR Lowest Price Target
Wall Street Target
22 USD
21.61%
MNPR Average Price Target
Wall Street Target
22 USD
21.61%
MNPR Highest Price Target
Wall Street Target
22 USD
21.61%
REVENUE FORECAST
Revenue Forecast Chart MNPR
EBIT FORECAST
EBIT Forecast Chart MNPR
NET INCOME FORECAST
Net Income Chart MNPR